Zhigang Tian

29PUBLICATIONS
56CO-AUTHORS
Innate immunityGenome structure and regulationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 10, 2026
The inhibitory receptor CD200R educates ILC1s for optimal cytotoxicity.

|Jul 16, 2026
ASB2 inhibits lipid accumulation to promote ILC1 homeostatic fitness and anti-tumor immunity in the mouse liver.

|Oct 17, 2025
αTIGIT-IL2 achieves tumor regression by promoting tumor-infiltrating regulatory T cell fragility in mouse models.

Tianci Wang, Yupu Xu, Zhengfeng Zhang

|Jul 11, 2025
Innate lymphoid cells originate from fetal liver-derived tissue-resident progenitors.

Xianwei Wang, Jiarui Li, Lucas Rebuffet

|Nov 21, 2024
CD49a Targeting Enhances NK Cell Function and Antitumor Immunity.

Yu Zhang, Yangyang Li, Zhengfeng Zhang

|Aug 27, 2024
Author Correction: Targeting myeloid-derived suppressor cells promotes antiparasitic T-cell immunity and enhances the efficacy of PD-1 blockade.

Chuanshan Zhang, Hui Wang, Tuerganaili Aji

Pageof 5

Frequent Collaborators

15 joint publications

Rui Sun

9 joint publications

Hui Peng

9 joint publications

Haoyu Sun

7 joint publications

Haiming Wei